Dehydrocorydaline
Dehydrocorydaline (13-Methylpalmatine) is a bioactive small molecule with demonstrated anti-metastatic, antiplatelet, and anti-inflammatory properties in vitro. It modulates key pathways including MMPs, Bcl-2/Bax, and p38 MAPK, affecting cancer cell apoptosis, myoblast differentiation, and platelet aggregation, making it a valuable research tool in oncology, cardiovascular, and inflammation studies.
Product Specifications
CAS Number
30045-16-0
Product Name Alternative
Parasite, PARP, inhibit, Inhibitor, Dehydrocorydalin, Dehydrocorydaline, Autophagy, Bcl-2 Family, Bcl-2, Caspase, 13-Methylpalmatine, poly ADP ribose polymerase, p38 MAPK, p38MAPK
Field of Research
Cell Biology, Epigenetics & Chromatin, Infectious Disease & Virology, Molecular Biology, Protein Biochemistry, Signal Transduction
Purity
98.36% (May vary between batches)
Solubility
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.:Soluble;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (13.65 mM) ; DMSO:66 mg/mL (180.12 mM)
Smiles
CC1=C2C=3C (=CC (OC) =C (OC) C3) CC[N+]2=CC=4C1=CC=C (OC) C4OC
Molecular Formula
C22H24NO4
Molecular Weight
366.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
